2 months Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva Zacks
AXSM stock rises 20% as it settles Auvelity patent litigation with Teva, protecting the drug’s exclusivity in the United States at least until Sept. 30, 2038.
XAXSM stock rises 20% as it settles Auvelity patent litigation with Teva, protecting the drug’s exclusivity in the United States at least until Sept. 30, 2038.
XThe Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.